Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fluence Energy Inc. Class A Common Stock (FLNC) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

Fluence Energy Inc. Class A Common StockTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Fluence Energy Inc. Class A Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Fluence Energy Inc. Class A Common Stock trades at $5.99 (market cap $888.33M), while Royalty Pharma plc Class A Ordinary Shares trades at $59.89 (market cap $26.26B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 29.6× Fluence Energy Inc. Class A Common Stock's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.59% dividend while Fluence Energy Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fluence Energy Inc. Class A Common Stock for 0 Days and Royalty Pharma plc Class A Ordinary Shares for 6 Days on average.

FLNCRPRX
Market Cap
$888.33M$26.26B
Volume
7,350,8992,828,067
Sector
UtilitiesHealth
52-Week High
$32.23$63.96
52-Week Low
$6.21$36.18
Typical Hold Time
0 Days6 Days
Enterprise Value
$941.17M$33.49B
Dividend Yield
—1.59%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fluence Energy Inc. Class A Common Stock

No Aura AI signal available yet.

Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma (RPRX) trades at $56.57, down 2.09% on the day, with a bullish technical signal and strong fundamentals. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue and net income show steady growth, supported by a high gross profit margin of 89.38%. Analyst consensus is unanimously bullish with a $63.33 price target.

The outlook remains positive given earnings momentum and strategic capital deployment, though risks include biopharma policy shifts and reliance on partner drug performance. The stock offers exposure to a diversified portfolio of blockbuster drugs with minimal operational risk, but investors should monitor upcoming earnings and broader sector dynamics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLNC
100% Buy0% Sell
Avg holding period · 0 Days
RPRX

No sentiment data available yet.

Top news

Latest headlines on both assets

About Fluence Energy Inc. Class A Common Stock

Fluence Energy Inc. designs and delivers energy storage products, operational services, and asset optimization software for renewable-energy and storage applications worldwide.

Read more on FLNC →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →